Sign in
4/A

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001177648-18-000037

Options or other derivatives

  • Senior Vice President acquired 70,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Ocain Tim · Senior Vice President

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2014-01-30 Grant or award : show line 1 in the form Stock Option (right to buy) +70,000 $32.27 2024-01-30 70,000 70,000 D
Loading xslF345X03/edgar.xml…